Demiröz AS, et al: Blastic Plasmacytoid Dendritic Cell Neoplasia: A Single Center Experience Turk J Hematol 2020;37:48-52References1. Adachi M, Maeda K, Takekawa M, Hinoda Y, Imai K, Sugiyama S, Yachi A.High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positiveLymphoma. Am J Hematol 1994;47:278-282.2. Swerdlow SH, Campo E, Harris NL, et al., editors. WHO Classification ofTumours of Haematopoietic and Lymphoid Tissues, 3th ed. Lyon France:IARC Press; 2008. p. 146-147.3. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, (Eds.)WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. InWorld Health Organization Classification of Tumours, 4th ed.; InternationalAgency for Research on Cancer: Lyon, France, 2017.4. Sapienza MR, Pileri A, Derenzini E, Melle F, Motta G, Fiori S, Calleri A,Pimpinelli N, Tabanelli V, Pileri S. Blastic plasmacytoid dendritic cellneoplasm: state of the art and prospects. Cancers (Basel) 2019;11.5. Julia F, Dalle S, Duru G, Balme B, Vergier B, Ortonne N, Vignon-Pennamen MD,Costes-Martineau V, Lamant L, Dalac S, Delattre C, Déchelotte P, CourvilleP, Carlotti A, De Muret A, Fraitag S, Levy A, Mitchell A, Petrella T. Blasticplasmacytoid dendritic cell heoplasms. Am J Surg Pathol 2014;38:673-680.6. Jegalian AG, Buxbaum NP, Facchetti F, Raffeld M, Pittaluga S, WayneAS, Jaffe ES. Blastic plasmacytoid dendritic cell neoplasm in children :diagnostic features and clinical implications. Haematologica 2010;95:1873-1879.7. Nizza D, Simoneaux SF. Blastic plasmacytoid dendritic cell neoplasmpresenting as a subcutaneous mass in an 8-year-old boy. Pediatr Radiol2010;40 Suppl 1:S40-42.8. Julia F, Petrella T, Beylot-Barry M, Bagot M, Lipsker D, Machet L, Joly P,Dereure O, Wetterwald M, d’Incan M, Grange F, Cornillon J, Tertian G,Maubec E, Saiag P, Barete S, Templier I, Aubin F, Dalle S. Blastic plasmacytoiddendritic cell neoplasm : clinical features in 90 patients. Br J Dermatol2013;169:579-586.9. Murphy N, Owens D, Hinds E, Nelson N. Blastic plasmacytoid dendritic cellneoplasm (BPDCN) in leukaemic phase without skin lesions: a diagnosticand management challenge. Pathology 2019;51:439-441.10. Petrella T, Bagot M, Willemze R, Beylot-Barry M, Vergier B, Delaunay M,Meijer CJ, Courville P, Joly P, Grange F, De Muret A, Machet L, DompmartinA, Bosq J, Durlach A, Bernard P, Dalac S, Dechelotte P, D’Incan M,Wechsler J, Teitell MA. Blastic NK-cell lymphomas (agranular CD4+CD56+hematodermic neoplasms): a review. Am J Clin Pathol 2005;123:662-675.11. Jegalian AG, Facchetti F, Jaffe ES. Plasmacytoid dendritic cells. Adv AnatPathol 2009;16:392-404.12. Feuillard J. Clinical and biologic features of CD4+CD56+ malignancies.Blood 2002;99:1556-1563.13. Shi Y, Wang E. Blastic plasmacytoid dendritic cell neoplasm: Aclinicopathologic review. Arch Pathol Lab Med 2014;138:564-569.14. Petrella T, Comeau MR, Maynadié M, Couillault G, De Muret A, MaliszewskiCR, Dalac S, Durlach A, Galibert L. “Agranular CD4+ CD56+ hematodermicneoplasm” (blastic NK-cell lymphoma) originates from a population ofCD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol2002;26:852-862.15. Osaki Y, Yokohama A, Saito A, Tahara K, Yanagisawa K, Ogawa Y, Ishizaki T,Mitsui T, Koiso H, Takizawa M, Uchiumi H, Saitoh T, Handa H, Murakami H,Tsukamoto N, Nojima Y. Characterization of CD56+ dendritic-like cells: anormal counterpart of blastic plasmacytoid dendritic cell neoplasm? PLoSOne 2013;8:e81722.16. Petrella T, Meijer CJ, Dalac S, Willemze R, Maynadié M, Machet L, CasasnovasO, Vergier B, Teitell MA. TCL1 and CLA expression in agranular CD4/CD56hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis.Am J Clin Pathol 2004;122:307-313.17. Ascani S, Massone C, Ferrara G, Rongioletti F, Papini M, Pileri S, Cerroni L.CD4-negative variant of CD4+/CD56+ hematodermic neoplasm: Descriptionof three cases. J Cutan Pathol 2008;35:911-915.18. Cota C, Vale E, Viana I, Requena L, Ferrara G, Anemona L, Metze D, Fink-Puches R, Wiesner T, Cerroni L. Cutaneous manifestations of blasticplasmacytoid dendritic cell neoplasm - morphologic and phenotypicvariability in a series of 33 patients. Am J Surg Pathol 2010;34:75-87.19. Weaver J, Hsi ED CD4+/CD56+ hematodermic neoplasm (blastic NK-celllymphoma). J Cutan Pathol 2008;35:975-977.20. Petrella T, Facchetti F. Tumoral aspects of plasmacytoid dendritic cells: whatdo we know in 2009? Autoimmunity 2010;43:210-214.21. Marafioti T, Paterson JC, Ballabio E, Reichard KK, Tedoldi S, HollowoodK, Dictor M, Hansmann ML, Pileri SA, Dyer MJ, Sozzani S, Dikic I, ShawAS, Petrella T, Stein H, Isaacson PG, Facchetti F, Mason DY. Novel markersof normal and neoplastic human plasmacytoid dendritic cells. Blood2008;111:3778-379222. Kim HS, Kim HJ, Kim SH, Choi JY, Ko YH, Kim WS, Jung CW, Kim SJ. Clinicalfeatures and treatment outcomes of blastic plasmacytoid dendritic cellneoplasm: a single-center experience in Korea. Korean J Intern Med2017;32:890-899.23. Pagano L, Valentini CG, Grammatico S, Pulsoni A. Blastic plasmacytoiddendritic cell neoplasm: diagnostic criteria and therapeutical approaches.Br J Haematol 2016;174:188–202.24. Aoki T, Suzuki R, Kuwatsuka Y, Kako S, Fujimoto K, Taguchi J, KondoT, Ohata K, Ito T, Kamoda Y, Fukuda T, Ichinohe T, Takeuchi K, Izutsu K,Suzumiya J. Long-term survival following autologous and allogeneic stemcell transplantation for blastic plasmacytoid dendritic cell neoplasm. Blood2015;125:3559-3562.25. Riaz W, Zhang L, Horna P, Sokol L. Blastic plasmacytoid dendritic cellneoplasm: update on molecular biology, diagnosis, and therapy. CancerControl 2014;21:279-289.52
IMAGES IN HEMATOLOGYDOI: 10.4274/tjh.galenos.2019.2019.0068Turk J Hematol 2020;37:53-54Kasabach-Merritt Syndrome in an AdultYetişkinde Kasabach Merritt SendromuMilan Pantelic 1 , Masa Pantelic 2 , Petar Djuric 3 , Katarina Markovic 4 , Tamara Vucinic 1 , Jovan Todor Juloski 51Zvezdara University Medical Center, Department of Radiology, Belgrade, Serbia2Zvezdara University Medical Center, Department of Gastroenterology, Belgrade, Serbia3Zvezdara University Medical Center, Department of Nephrology, Belgrade, Serbia4Zvezdara University Medical Center, Department of Hematology, Belgrade, Serbia5Zvezdara University Medical Center, Department of Surgery, Belgrade, SerbiaFigure 1. Multislice computed tomography showed a largeretroperitoneal tumor.Figure 2. Multislice computed tomography showed a largeretroperitoneal tumor.©Copyright 2020 by Turkish Society of HematologyTurkish Journal of Hematology, Published by Galenos Publishing HouseAddress for Correspondence/Yazışma Adresi: Milan Pantelic, M.D., Zvezdara University Medical Center,Department of Radiology, Belgrade, SerbiaPhone : +903816113810407E-mail : milan.pantelic.rs@gmail.com ORCID: orcid.org/0000-0001-7366-2425Received/Geliş tarihi: February 17, 2019Accepted/Kabul tarihi: May 20, 201953
- Page 1:
Volume 37 Issue 1March 2020E-ISSN:
- Page 4 and 5:
Contact InformationEditorial Corres
- Page 6 and 7:
TURKISH JOURNAL OF HEMATOLOGYINSTRU
- Page 8 and 9:
published research articles on the
- Page 10 and 11:
e-mail address. The system will sen
- Page 12 and 13:
59 Children with Iron Deficiency An
- Page 14 and 15: Aladağ E, et al: Acute Graft-Versu
- Page 16 and 17: Aladağ E, et al: Acute Graft-Versu
- Page 18 and 19: Koca D, et al: Therapeutic Potentia
- Page 20 and 21: Koca D, et al: Therapeutic Potentia
- Page 22 and 23: Koca D, et al: Therapeutic Potentia
- Page 24 and 25: Koca D, et al: Therapeutic Potentia
- Page 26 and 27: Li SJ, et al: The Efficacy and Safe
- Page 28 and 29: Li SJ, et al: The Efficacy and Safe
- Page 30 and 31: Li SJ, et al: The Efficacy and Safe
- Page 32 and 33: RESEARCH ARTICLEDOI: 10.4274/tjh.ga
- Page 34 and 35: Matsumura A, et al: ST2 for Transpl
- Page 36 and 37: Matsumura A, et al: ST2 for Transpl
- Page 38 and 39: Matsumura A, et al: ST2 for Transpl
- Page 40 and 41: Matsumura A, et al: ST2 for Transpl
- Page 42 and 43: RESEARCH ARTICLEDOI: 10.4274/tjh.ga
- Page 44 and 45: Niazkar HR, et al: First-time Blood
- Page 46 and 47: Niazkar HR, et al: First-time Blood
- Page 48 and 49: RESEARCH ARTICLEDOI: 10.4274/tjh.ga
- Page 50 and 51: Gonzalez-Mancera MS, et al: Double-
- Page 52 and 53: Gonzalez-Mancera MS, et al: Double-
- Page 54 and 55: PERSPECTIVES IN HEMATOLOGYDOI: 10.4
- Page 56 and 57: Haznedaroğlu İC, et al: Tyrosine
- Page 58 and 59: Haznedaroğlu İC, et al: Tyrosine
- Page 60 and 61: BRIEF REPORTDOI: 10.4274/tjh.galeno
- Page 62 and 63: Demiröz AS, et al: Blastic Plasmac
- Page 66 and 67: Pantelic M, et al: Kasabach-Merritt
- Page 68 and 69: Ardıçoğlu Akışın Y and Akar N
- Page 70 and 71: LETTERS TO THE EDITOR Turk J Hemato
- Page 72 and 73: LETTERS TO THE EDITORTurk J Hematol
- Page 74 and 75: LETTERS TO THE EDITORTurk J Hematol
- Page 76 and 77: LETTERS TO THE EDITORTurk J Hematol
- Page 78 and 79: LETTERS TO THE EDITORTurk J Hematol
- Page 80 and 81: LETTERS TO THE EDITORTurk J Hematol
- Page 82 and 83: LETTERS TO THE EDITORTurk J Hematol
- Page 84 and 85: LETTERS TO THE EDITORTurk J Hematol
- Page 86 and 87: LETTERS TO THE EDITORTurk J Hematol
- Page 88: LETTERS TO THE EDITORTurk J Hematol